Navigation Links
Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men
Date:7/16/2009

SANTA CLARA, Calif., July 16 /PRNewswire/ -- Lumenis' High Speed LightSheer(R) Duet(TM) for permanent hair reduction was featured recently in the New York Times Fashion & Style section with Dr. Arielle Kauvar, Clinical Associate Professor of Dermatology New York University Medical Center and Founding Director, New York Laser & Skin Care. During the interview, Dr. Kauvar described the LightSheer Duet as a welcome relief for men seeking a smoother appearance, with reduction in treatment time and improved patient comfort. "Men who wanted to have their back hair removed permanently, for example, often had to sit with a topical anesthetic for an hour before each of a half-dozen visits, so there used to be the 'time and pain and nuisance' factor." With the advent of the High Speed LightSheer Duet welcome relief has arrived. Now 'big swaths of hair can be removed in multiple 15-minute treatments," stated Dr. Kauvar.

To read the New York Times Fashion & Style piece with Dr. Arielle Kauvar discussing why she prefers the speed and comfort of the LightSheer Duet over older hair removal methods with their 'time and pain and nuisance factors', go to: http://www.aesthetic.lumenis.com/wt/page/inthenews

To watch side-by-side comparisons of the NEW High Speed LightSheer Duet with versus other lasers in terms of treatment speed and comfort, visit: http://www.highspeedlightsheer-challenge.com

"Clearly men accept that excessive body hair can be unattractive and uncomfortable. However, very few have the patience to subject themselves to lengthy hair removal procedures, particularly if pain is involved. Thanks to the new High Speed LightSheer Duet, these men will now be able to schedule appointments that are far more convenient, get in and have their back or chest treated with speed and comfort, get out and return to their normal routine," said Mr. Robert Mann, General Manager of Lumenis Global Aesthetics & Dermatology Business.

The American Society for Aesthetic Plastic Surgery estimates 14% of the 1.3 million laser hair removal procedures performed in 2008 within the US alone were for men, whereas 83% for women (www.surgery.org). Other reports estimate procedure volume to be much higher. Faster and comfortable treatment alternatives such as the new High Speed LightSheer Duet have the potential to expand this market significantly. Clinicians already report an increase in number of younger men seeking laser hair removal in general. This is further supported by online advertorials for major razor manufacturers geared towards attracting and educating younger men on the benefits of shaving multiple body areas.

"Laser hair removal offers permanent results for long term satisfaction -- actual reduction in hair count and thickness. This is a major advantage over the temporary satisfaction and ongoing nuisance associated with shaving or waxing," added Dr. Mitchel P. Goldman, MD. Clinical Professor Dermatology/Medicine, University of California, San Diego and Medical Director of La Jolla Spa MD. "I have personally tried all of the various hair removal lasers developed over the past 18 years, to remove the hair on my own back in addition to my patients. The new LightSheer Duet is the best by far! The procedure was literally painless for me, and took only 15 minutes. Actually, I'm still nearly hair free four months post treatment. This is definitely the best thing I've ever done for my back."

About Lumenis' LightSheer Duet

The LightSheer Duet features two hair removal systems on one versatile platform enabling clinicians to optimize permanent hair reduction anywhere on the body. The platform also includes the LightSheer ET system, which is ideal for smaller or bony areas such as the upper lip, chin, or around the ankles. The performance of this system is well documented and clinically validated, satisfying customers worldwide with over 6000 LightSheer systems installed.

The New LightSheer HS (High Speed handpiece) features a large 22x35 mm diode array that is designed for treating large areas such as legs, arms, chests, abdomen, shoulders and backs. LightSheer HS employs fully integrated vacuum assist technology to gently lift skin into the treatment aperture prior to applying laser energy. With this approach, the targeted tissue is gently stretched and thinned, minimizing competing chromophores by blanching vessels and spreading skin pigmentation over a larger area, in addition to pulling the hair follicle closer to the skin's surface. The cumulative result is that energy is delivered more efficiently to achieve excellent clinical results with speed and comfort. These combined features allow clinicians to treat large areas easily and quickly, leading to a significant reduction in treatment time, which essentially eliminates clinician fatigue and revolutionizes treatment economics.

About Lumenis

Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for aesthetic, surgical and ophthalmic applications, is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

    Lumenis Contact:
    Michelle Maydan
    Director of Corporate Communications
    1-866-569-0597
    +972-4-959-9004
    e-mail: mmaydan@lumenis.com

Lumenis((R)) is a registered trademark of Lumenis Ltd.

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "project" or other similar words, but are not the only way these statements are identified. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled "Risk Factors", as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis Ltd. Announces Senior Leadership Appointments Strengthening the Companys Strategic Businesses
3. Alma Lasers Answers Lumenis Complaint
4. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
5. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
6. Lumenis Announces changes in Lumenis Vision Strategic Business Unit
7. Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting
8. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
9. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
10. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
11. Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papules (PPP) Procedure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: